Physician profile
Chandra Ala
NPI 1992990089
$5,907.90
in general payments reported to CMS, 2019-2025
33 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $390 · 2021: $864 · 2022: $1,433 · 2023: $1,884 · 2024: $623 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,732 · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,732.40 |
| Education | $147.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $927.64 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $833.70 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $551.26 | 2022-2023 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $417.77 | 2022-2024 | Cardiomems |
| Boston Scientific Corporation | $393.99 | 2020-2025 | Eluvia, Avvigo Guidance System, Opticross |
| Amgen INC. | $355.21 | 2019-2023 | Repatha |
| Teleflex LLC | $300.56 | 2022-2025 | Turnpike |
| Janssen Pharmaceuticals, INC | $233.07 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $196.43 | 2022-2025 | Assure Wcd |
| Pfizer INC. | $161.47 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $156.99 | 2021-2024 | Camzyos |
| Bard Peripheral Vascular, INC. | $147.68 | 2023 | |
| Kiniksa Pharmaceuticals, Ltd. | $136.34 | 2021-2022 | |
| Angiodynamics, INC. | $127.53 | 2019-2023 | Alphavac |
| Elutia, INC. | $120.91 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $112.12 | 2019 | |
| Truvic Medical, INC. | $100.00 | 2022 | |
| Chiesi USA, INC. | $88.39 | 2023-2024 | Kengreal, Cleviprex |
| Esperion Therapeutics, INC. | $77.53 | 2021 | |
| Lantheus Medical Imaging, INC. | $72.72 | 2021 | |
| Cardiva Medical, INC. | $50.00 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Shockwave Medical, INC | $46.27 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $45.07 | 2023 | Angio-Seal |
| Astrazeneca Pharmaceuticals Lp | $41.00 | 2021-2023 | Farxiga |
| Alnylam Pharmaceuticals INC. | $29.49 | 2021 | |
| Cardiovascular Systems INC. | $23.65 | 2021 | |
| Akcea Therapeutics, INC. | $22.64 | 2020 | |
| Sobi, INC | $22.61 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.21 | 2025 | Jardiance |
| Janssen Scientific Affairs, LLC | $17.33 | 2023 | Xarelto |
| Novo Nordisk INC | $16.81 | 2023 | Ozempic |
| Merck Sharp & Dohme LLC | $15.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Ala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.